What is the appropriate management and risk stratification for a 36-year-old diabetic male post‑kidney transplant who presents with a non‑healing left foot ulcer, hyperkalemia with tall T waves on electrocardiogram, sinus tachycardia, normal chest radiograph, and impaired renal function (creatinine approximately 3 mg/dL)?

Immediate Management: Hyperkalemia Takes Priority

This patient requires urgent treatment of hyperkalemia before addressing the foot ulcer—tall T waves on ECG represent a life-threatening cardiac emergency that demands immediate intervention to prevent fatal arrhythmias, followed by comprehensive diabetic foot management and optimization of immunosuppressive therapy. 1

Critical First Steps: Stabilize the Cardiac Risk

Hyperkalemia Management (Immediate Priority)

The tall T waves indicate significant hyperkalemia requiring emergency treatment:

Acute stabilization sequence:

• Administer calcium gluconate or calcium chloride IV immediately for cardiac membrane stabilization
• Follow with insulin/dextrose to shift potassium intracellularly
• Consider salbutamol nebulization as adjunct
• Monitor continuous cardiac telemetry 1

Identify and correct reversible factors:

• Review all medications: calcineurin inhibitors (tacrolimus/cyclosporine), trimethoprim-sulfamethoxazole for PCP prophylaxis, and any RAAS inhibitors are likely culprits 2, 3
• Check for metabolic acidosis (obtain venous blood gas)
• Assess for constipation
• Evaluate dietary potassium intake 1

Post-transplant specific considerations: The creatinine of 3 mg/dL suggests graft dysfunction, which combined with immunosuppressive medications creates a perfect storm for hyperkalemia. Calcineurin inhibitors cause hyperkalemic renal tubular acidosis through impaired distal tubular potassium secretion 2. Consider:

• Reducing tacrolimus/cyclosporine dose (target trough <10 ng/mL if feasible)
• Switching TMP-SMX to dapsone or atovaquone for PCP prophylaxis
• For chronic management, consider novel potassium binders (patiromer or sodium zirconium cyclosilicate) rather than discontinuing immunosuppression 2, 3

Secondary Priority: Diabetic Foot Ulcer Assessment

Risk Stratification

This patient is IWGDF Risk 3 (highest risk) due to:

• History of kidney transplant with end-stage renal disease 4
• Active non-healing foot ulcer
• Likely peripheral neuropathy and possible peripheral arterial disease

Critical vascular assessment required:

• Palpate foot pulses immediately
• Measure ankle-brachial index (ABI) and toe pressures
• Obtain pedal Doppler arterial waveforms 5

Healing probability indicators (measure these bedside tests):

• Toe pressure ≥30 mmHg suggests reasonable healing potential
• Transcutaneous oxygen pressure (TcPO₂) ≥25 mmHg increases healing probability by >25%
• Skin perfusion pressure ≥40 mmHg favorable 5

If toe pressure <30 mmHg or TcPO₂ <25 mmHg: Consider urgent vascular imaging and revascularization 5

Wound Management Protocol

Immediate wound care:

1. Sharp debridement of necrotic tissue, slough, and surrounding callus (strong recommendation) 6
2. Assess for infection using clinical signs (purulence, erythema >2 cm, warmth, pain/tenderness) 7
3. If infected: obtain deep tissue cultures or bone biopsy before antibiotics
4. Select dressings based on exudate control, comfort, and cost 6

For difficult-to-heal ulcers (if not improving after 6 weeks):

• Consider sucrose-octasulfate impregnated dressings for neuro-ischemic ulcers 6
• Consider hyperbaric oxygen therapy if ischemic component present 6
• Reassess vascular status and consider revascularization 5

Offloading is mandatory:

• Total contact cast or removable cast walker for plantar ulcers
• Prescribe therapeutic footwear with demonstrated pressure-relieving effect 4

Post-Transplant Specific Concerns

Prognosis Considerations

Critical evidence from transplant populations:

• Post-kidney transplant patients with diabetic foot ulcers do not have worse amputation or mortality outcomes compared to non-transplant diabetic patients, despite immunosuppression 8
• However, nearly 1 in 7 kidney transplant recipients develop new-onset DFU 9
• DFU in kidney-only transplant patients increases transplant failure risk 5-fold 9
• Advanced CKD (stages 4-5, which this patient has with creatinine 3) increases odds of non-healing ulcers 2.7-fold and 1-year mortality to 21.7% 10

Therefore, pursue aggressive limb salvage with multidisciplinary team involvement 8

Integrated Care Plan

Frequency of follow-up for IWGDF Risk 3:

• Foot examination every 1-3 months 4
• Immediate referral to multidisciplinary diabetic foot team
• Coordinate with transplant nephrology for immunosuppression optimization

Patient education (strong recommendations):

• Never walk barefoot, in socks alone, or thin-soled slippers
• Daily foot inspection for new lesions
• Daily foot washing with careful drying between toes
• Immediate contact with healthcare team for any new wounds 4

Common Pitfalls to Avoid

1. Do not discontinue immunosuppression to manage hyperkalemia—use alternative strategies first 1, 2
2. Do not delay vascular assessment—peripheral arterial disease is present in >50% of diabetic foot patients and requires urgent intervention if severe 5
3. Do not rely on wound cultures alone—clinical signs define infection, not colonization 7
4. Do not assume immunosuppression worsens outcomes—evidence shows similar healing rates with proper management 8
5. Do not focus solely on the foot—this patient needs simultaneous cardiac stabilization, renal optimization, and glycemic control